Diagnosis

Diagnosis

ISBN13: 9781522596554|ISBN10: 1522596550|ISBN13 Softcover: 9781522596561|EISBN13: 9781522596578
DOI: 10.4018/978-1-5225-9655-4.ch007
Cite Chapter Cite Chapter

MLA

Mahmoud Sakr. "Diagnosis." Diagnosing and Managing Hashimoto’s Disease: Emerging Research and Opportunities, IGI Global, 2020, pp.88-98. https://doi.org/10.4018/978-1-5225-9655-4.ch007

APA

M. Sakr (2020). Diagnosis. IGI Global. https://doi.org/10.4018/978-1-5225-9655-4.ch007

Chicago

Mahmoud Sakr. "Diagnosis." In Diagnosing and Managing Hashimoto’s Disease: Emerging Research and Opportunities. Hershey, PA: IGI Global, 2020. https://doi.org/10.4018/978-1-5225-9655-4.ch007

Export Reference

Mendeley
Favorite

Abstract

Clinically, a diffuse, firm goiter with pyramidal lobe enlargement, and without signs of thyrotoxicosis, should suggest the diagnosis of Hashimoto's thyroiditis (HT). The association of goiter with hypothyroidism is almost diagnostic. The thyroid stimulating hormone (TSH) is the sensitive marker of hypothyroidism and diagnosis of subclinical hypothyroidism. Thyroid perioxidase antibodies (TPO-Ab) and, less frequently, thyroglobulin antibodies (Tg-Ab) are elevated in the serum of patients with HT. Ultrasound may display an enlarged gland with normal texture, focal, or diffuse glandular enlargement with coarse, heterogenous, and hypo-echoic pattern, or a suggestion of multiple ill-defined micro-nodules. Color Doppler shows extensive hyper-vascularity. Histologically, the thyroid gland shows diffuse lymphocytic and plasma cell infiltration with formation of lymphoid follicles. Atrophy of the thyroid parenchyma is usually evident. It also reveals scant colloid, and a few epithelial cells, which may show Hurthle cell change. This chapter explores the diagnosis of Hashimoto's disease.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.